Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selinexor in Combination With Methotrexate and Rituximab for Relapsed /Refractory Central Nervous System (CNS) Lymphoma

NCT05698147 is registered in ClinicalTrials.gov with Tong Chen, MD as lead sponsor.

NCT NCT05698147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05698147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selinexor in Combination With Methotrexate and Rituximab for Relapsed /Refractory Central Nervous System (CNS) Lymphoma
Lead sponsor
Tong Chen, MD
Phase
Phase 1/2
Overall status
Recruiting
Start date
August 3, 2023
Completion date
December 31, 2026
Enrollment
30 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system lymphoma